SOUTH KOREA · OPENDART
BIONEERCORPORATION
바이오니아 · 064550 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
No exchange purchase by an insider is on record yet.
Other changes in holdings · 15
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-10-01 | OH JONG WAK | Director | Acquisition of shares upon exercise of call option(+) | 1,000 | DART ↗ |
| 2026-10-01 | HENA KIE | Director | Acquisition of shares upon exercise of call option(+) | 500 | DART ↗ |
| 2026-01-28 | Park Han-o | CEO | Donation(-) | 30,120 | DART ↗ |
| 2026-01-28 | Park Han-o | CEO | Donation(-) | 30,120 | DART ↗ |
| 2025-12-31 | LEE JOONG YEOL | Senior managing director | Others(+) | 100 | DART ↗ |
| 2025-12-31 | OH JONG WAK | Director | Others(+) | 701 | DART ↗ |
| 2025-12-31 | LEE SAM YONG | Director | Others(+) | 467 | DART ↗ |
| 2025-12-31 | HAN EUN SU | Director | Others(+) | 234 | DART ↗ |
| 2025-12-31 | KIM SUNG TAE | Managing director | Others(+) | 1,285 | DART ↗ |
| 2025-12-31 | LEE CHAN HYO | Managing director | Others(+) | 593 | DART ↗ |
| 2025-12-31 | HAM JUNG HOON | Director | Others(+) | 332 | DART ↗ |
| 2025-12-31 | HENA KIE | Director | Others(+) | 84 | DART ↗ |
| 2025-12-31 | LEE SANG GYU | Director | Others(+) | 467 | DART ↗ |
| 2025-09-12 | JEON GYU CHUL | Managing director | Acquisition of shares upon exercise of call option(+) | 2,000 | DART ↗ |
| 2025-06-04 | LEE JOONG YEOL | Senior managing director | Acquisition of shares upon exercise of call option(+) | 2,625 | DART ↗ |